M. Oettel

No ORCID on file · 4 papers in corpus · active 1995-2023

Study types

  • article 2
  • book-chapter 2

Condition tags

  • endometriosis 2
article 2023
Next step in the development of mesoprogestins: the preclinical profile of EC313
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1201547

INTRODUCTION: The pharmacological target for progesterone, different progestins, and Selective Progesterone Receptor Modulators (SPRMs) is the nuclear progesterone receptor (PR). EC313 is a new member of a subgroup of SPRMs, mesoprogestins,…

article 2006
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590500431482

High-dose dienogest (20 mg/day) was used for the treatment of endometriosis in women aged 18-52 years after laparoscopic and histological diagnosis of endometriosis and staging according to the revised American Fertility Society criteria. T…

book-chapter 1995
Untersuchung hormoneller Wirkungen von Dienogest in zellulären Testsystemen
·doi:10.1515/9783110813210-005
book-chapter 1995
Untersuchung hormoneller Wirkungen von Dienogest in zellulären Testsystemen
·doi:10.1515/9783112422168-005